ClinVar Genomic variation as it relates to human health
NM_000335.5(SCN5A):c.4844TCT[1] (p.Phe1616del)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000335.5(SCN5A):c.4844TCT[1] (p.Phe1616del)
Variation ID: 201572 Accession: VCV000201572.32
- Type and length
-
Microsatellite, 3 bp
- Location
-
Cytogenetic: 3p22.2 3: 38551520-38551522 (GRCh38) [ NCBI UCSC ] 3: 38593011-38593013 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Feb 27, 2016 Aug 25, 2024 Oct 13, 2023 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000335.5:c.4844TCT[1] MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000326.2:p.Phe1616del inframe deletion NM_001099404.2:c.4847TCT[1] MANE Plus Clinical Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_001092874.1:p.Phe1617del inframe deletion NM_001099404.2:c.4850_4852del MANE Plus Clinical Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NM_001099404.2:c.4850_4852delTCT MANE Plus Clinical Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NM_001099405.2:c.4793TCT[1] NP_001092875.1:p.Phe1599del inframe deletion NM_001160160.2:c.4748TCT[1] NP_001153632.1:p.Phe1584del inframe deletion NM_001160161.2:c.4685TCT[1] NP_001153633.1:p.Phe1563del inframe deletion NM_001354701.2:c.4790TCT[1] NP_001341630.1:p.Phe1598del inframe deletion NM_198056.2:c.4850_4852delTCT NM_198056.3:c.4847TCT[1] NP_932173.1:p.Phe1617del inframe deletion NM_198056.3:c.4850_4852del NC_000003.12:g.38551522AAG[1] NC_000003.11:g.38593013AAG[1] NG_008934.1:g.103148TCT[1] LRG_289:g.103148TCT[1] LRG_289t1:c.4850_4852del LRG_289t3:c.4850_4852del - Protein change
- F1616del, F1617del, F1584del, F1599del, F1598del, F1563del
- Other names
- -
- Canonical SPDI
- NC_000003.12:38551519:AGAAGAAG:AGAAG
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
SCN5A | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
3783 | 4224 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic/Likely pathogenic (6) |
criteria provided, multiple submitters, no conflicts
|
Oct 13, 2023 | RCV000183166.26 | |
Likely pathogenic (1) |
criteria provided, single submitter
|
May 11, 2015 | RCV000208172.9 | |
Pathogenic/Likely pathogenic (3) |
criteria provided, multiple submitters, no conflicts
|
Feb 1, 2018 | RCV000240624.13 | |
Pathogenic (1) |
criteria provided, single submitter
|
Feb 14, 2022 | RCV001836637.10 | |
Pathogenic/Likely pathogenic (2) |
criteria provided, multiple submitters, no conflicts
|
Jun 13, 2023 | RCV001842934.12 | |
Likely pathogenic (1) |
criteria provided, single submitter
|
Jul 14, 2023 | RCV002336464.10 | |
Pathogenic (1) |
criteria provided, single submitter
|
Feb 24, 2022 | RCV002500545.8 | |
Likely pathogenic (1) |
criteria provided, single submitter
|
May 17, 2023 | RCV003322601.8 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Likely pathogenic
(Jun 29, 2016)
|
criteria provided, single submitter
Method: clinical testing
|
Long QT syndrome 3
Affected status: yes
Allele origin:
germline
|
Center for Medical Genetics Ghent, University of Ghent
Accession: SCV000299257.2
First in ClinVar: Sep 09, 2016 Last updated: Sep 09, 2016 |
Comment:
This variant has not been identified in large population databases (Gnomad, 1000 Genomes, Go NL, Exome Variant Server). In addition, the variant has been reported … (more)
This variant has not been identified in large population databases (Gnomad, 1000 Genomes, Go NL, Exome Variant Server). In addition, the variant has been reported previously in individuals with longQT syndrome. The variant results in an inframe deletion of one amino acid and thus reduces the length of the protein. Functional studies demonstrated that this variant alters sodium current kinetics (PMID: 14523039; PMID: 15665061). (less)
Sex: female
|
|
Likely pathogenic
(Oct 23, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
(Unknown mechanism)
Affected status: yes
Allele origin:
germline
|
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen
Accession: SCV001447215.1
First in ClinVar: Nov 28, 2020 Last updated: Nov 28, 2020 |
Clinical Features:
Ventricular arrhythmia (present) , Cardiac arrest (present)
Sex: female
|
|
Likely pathogenic
(Oct 13, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000235582.13
First in ClinVar: Jul 05, 2015 Last updated: Nov 25, 2023 |
Comment:
Reported in multiple individuals in association with LQTS, Brugada syndrome, and sick sinus syndrome (SSS) (Splawski et al., 2000; Benson et al., 2003; Liang et … (more)
Reported in multiple individuals in association with LQTS, Brugada syndrome, and sick sinus syndrome (SSS) (Splawski et al., 2000; Benson et al., 2003; Liang et al., 2006; Kapplinger et al., 2009, Zellerhoff et al., 2009; Liang et al., 2010; Crotti et al., 2012; Tan et al., 2014; Itoh et al., 2016; Fukuyama et al., 2020); Identified in 45 individuals from a large Dutch-German founder population, including one homozygous individual, and found that this variant segregated with divergent and overlapping cardiac phenotypes including LQTS, cardiac conduction disease (CCD), BrS, and isorhythmic dissociation (Ter Bekke et al., 2017); Published functional studies demonstrated that this variant alters sodium current kinetics and may cause both gain-of-function and loss-of-function effects on sodium currents, depending on the membrane potential (Benson et al., 2003; Chen et al., 2005; Gui et al., 2010); Not observed at significant frequency in large population cohorts (gnomAD); In-frame deletion of one amino acid in a non-repeat region; In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 14523039, 20539757, 15665061, 17081365, 19017345, 20877689, 22840528, 25236808, 26669661, 20448214, 28782696, 19716085, 24578642, 29017927, 30364184, 31582838, 32454217, 31737537, 32780330, 34426522, 33221895, 10973849, 32161207, 33673806) (less)
|
|
Likely pathogenic
(May 11, 2015)
|
criteria provided, single submitter
Method: clinical testing
|
Long QT syndrome
Affected status: yes
Allele origin:
germline
|
Blueprint Genetics
Accession: SCV000264218.2
First in ClinVar: Feb 27, 2016 Last updated: Feb 27, 2016 |
Number of individuals with the variant: 1
|
|
Pathogenic
(May 13, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Not provided
Affected status: unknown
Allele origin:
germline
|
Johns Hopkins Genomics, Johns Hopkins University
Accession: SCV001711934.1
First in ClinVar: Jun 08, 2021 Last updated: Jun 08, 2021 |
Comment:
This variant (rs749697698) is rare in a large population database (5/250930 total alleles, 0.002%, no homozygotes) and has an entry in ClinVar. This variant has … (more)
This variant (rs749697698) is rare in a large population database (5/250930 total alleles, 0.002%, no homozygotes) and has an entry in ClinVar. This variant has been reported in families and/or individuals with autosomal dominant long QT syndrome-3 or Brugada syndrome-1. This variant causes a deletion of a single phenylalanine residue in the SCNA5 protein, which is located in the short extracellular loop between segments S3 and S4 in the repeat domain IV. Functional studies using cultured mammalian cells have demonstrated that this variant alters sodium current kinetics and may cause either an increase or decrease in sodium currents, depending on the membrane potential. We consider this variant to be pathogenic. (less)
|
|
Pathogenic
(Oct 14, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
Not provided
Affected status: unknown
Allele origin:
germline
|
Mayo Clinic Laboratories, Mayo Clinic
Accession: SCV001713284.1
First in ClinVar: Jun 15, 2021 Last updated: Jun 15, 2021 |
Comment:
PS3, PP1_Strong PM4
Number of individuals with the variant: 1
|
|
Pathogenic
(Aug 01, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Cardiac arrhythmia
Affected status: unknown
Allele origin:
germline
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Accession: SCV002572033.1
First in ClinVar: Sep 17, 2022 Last updated: Sep 17, 2022 |
Comment:
Variant summary: SCN5A c.4850_4852delTCT (p.Phe1617del) results in an in-frame deletion that is predicted to remove one amino acid from the encoded protein. The variant allele … (more)
Variant summary: SCN5A c.4850_4852delTCT (p.Phe1617del) results in an in-frame deletion that is predicted to remove one amino acid from the encoded protein. The variant allele was found at a frequency of 2e-05 in 255580 control chromosomes (gnomAD). c.4850_4852delTCT has been reported in the literature in multiple individuals affected LQTS (examples: Splawski_2000, Kapplinger_2009, Goldenberg_2011), Sick Sinus syndrome (example: Benson_2003) and Brugada syndrome (examples: Liang_2010 and Crotti_2012). These data indicate that the variant is very likely to be associated with disease. Multiple functional studies demonstrated that this variant alters sodium current kinetics and may cause either an increase or decrease in sodium currents (examples: Benson_2003, Chen_2005, Butters_2010 and Gui_2010). Eleven submitters have provided clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as pathogenic (n=5) and likely pathogenic (n=6). Based on the evidence outlined above, the variant was classified as pathogenic. (less)
|
|
Pathogenic
(Feb 24, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Progressive familial heart block, type 1A
SUDDEN INFANT DEATH SYNDROME Brugada syndrome 1 Dilated cardiomyopathy 1E Ventricular fibrillation, paroxysmal familial, type 1 Long QT syndrome 3 Sick sinus syndrome 1 Atrial fibrillation, familial, 10
Affected status: unknown
Allele origin:
unknown
|
Fulgent Genetics, Fulgent Genetics
Accession: SCV002814934.1
First in ClinVar: Dec 31, 2022 Last updated: Dec 31, 2022 |
|
|
Likely pathogenic
(Jun 13, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Cardiac arrhythmia
Affected status: unknown
Allele origin:
germline
|
Color Diagnostics, LLC DBA Color Health
Accession: SCV001734337.2
First in ClinVar: Jun 19, 2021 Last updated: Feb 14, 2024 |
Comment:
This variant causes a deletion of phenylalanine at codon 1617 of the SCN5A protein. This variant is also known as Phe1616del in the literature based … (more)
This variant causes a deletion of phenylalanine at codon 1617 of the SCN5A protein. This variant is also known as Phe1616del in the literature based on a different NM_000335 transcript. This variant is found within a highly conserved region of the transmembrane domain DIV. Rare nontruncating variants in this region (a.a. 1530-1771) have been shown to be significantly overrepresented in individuals with long QT syndrome or Brugada syndrome (PMID: 32893267). Functional studies have shown that this variant causes a reduced peak sodium current density and also an increased sodium current at positive command potentials (PMID: 14523039, 15665061, 20448214). This variant has been reported in 45 individuals of the Netherlands and Germany descents in a 16-generation pedigree and has been shown to highly associate and segregate with long QT syndrome (PMID: 28782696). Some carriers in this founder population also exhibited other overlapping cardiac phenotypes including cardiac conduction defect, Brugada syndrome and/or isorhythmic atrioventricular dissociation. This variant has been observed in another two unrelated individuals affected with long QT syndrome (PMID: 10973849, 32454217), one individual affected with congenital sick sinus syndrome (PMID: 14523039), one with sudden explained death (PMID: 34620408), and several individuals with or suspected with Brugada syndrome (PMID: 20877689, 22840528, 32893267, 33221895, 36516610). This variant has been identified in 5/250930 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Based on the available evidence, this variant is classified as Likely Pathogenic. (less)
|
|
Likely pathogenic
(Jul 14, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Cardiovascular phenotype
Affected status: unknown
Allele origin:
germline
|
Ambry Genetics
Accession: SCV002634870.3
First in ClinVar: Nov 29, 2022 Last updated: May 01, 2024 |
Comment:
The c.4850_4852delTCT variant (also known as p.F1617del) is located in coding exon 27 of the SCN5A gene. This variant results from an in-frame TCT deletion … (more)
The c.4850_4852delTCT variant (also known as p.F1617del) is located in coding exon 27 of the SCN5A gene. This variant results from an in-frame TCT deletion at nucleotide positions 4850 to 4852. This results in the in-frame deletion of a phenylalanine residue at codon 1617, located in the extracellular loop that links the S3 and S4 transmembrane-spanning helices of the DIV domain. This variant has been detected in individuals reported to have, or referred for genetic testing for, long QT syndrome (LQTS) and Brugada syndrome (BrS) (Splawski I et al. Circulation. 2000;102(10):1178-85; Kapplinger JD et al. Heart Rhythm. 2009;6(9):1297-303; Liang P et al. J Cardiovasc Dis Res. 2010;1(2):69-74; Crotti L et al. J Am Coll Cardiol. 2012;60(15):1410-8). This variant has also been reported to co-occur with other variants in arrhythmia-related genes, including a case of pediatric onset sick sinus syndrome, and severe LQTS where relatives with only this alteration were unaffected or less severely affected (Benson DW et al. J Clin Invest. 2003;112(7):1019-28; Tan VH et al. Heart Lung. 2014;43(6):541-5). One study of a Dutch-German population reported this alteration as a founder mutation that was significantly associated with the risk of long QT syndrome (Ter Bekke RMA et al. Heart Rhythm. 2017 12;14(12):1873-1881). Functional studies have suggested this variant alters sodium channel kinetics; however, the physiological relevance of the observed impact is unclear (Benson DW et al. J Clin Invest. 2003;112(7):1019-28; Chen T et al. Am J Physiol Heart Circ Physiol. 2005;288(6):H2666-76; Gui J. PLoS ONE. 2010;5(6):e10985). This amino acid position is highly conserved through mammals but not in all available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Based on the majority of available evidence to date, this variant is likely to be pathogenic. (less)
|
|
Pathogenic
(Feb 01, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
Long QT syndrome 3
Affected status: yes
Allele origin:
unknown
|
Center For Human Genetics And Laboratory Diagnostics, Dr. Klein, Dr. Rost And Colleagues
Accession: SCV000805140.1
First in ClinVar: Sep 09, 2016 Last updated: Sep 09, 2016 |
|
|
Pathogenic
(Feb 14, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Sick sinus syndrome 1
Affected status: yes
Allele origin:
germline
|
DASA
Accession: SCV002097306.1
First in ClinVar: Feb 20, 2022 Last updated: Feb 20, 2022 |
Comment:
This sequence change has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 201572; PMID: 28782696; 25236808) - PS4. … (more)
This sequence change has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 201572; PMID: 28782696; 25236808) - PS4. The variant is present at low allele frequencies population databases (rs749697698 - gnomAD 0.0001993%; ABraOM no frequency - http://abraom.ib.usp.br/) - PM2_supporting. Protein length variants as a result of in-frame deletions/insertions in a nonrepeat region or stop-loss variants - PM4. The variant co-segregated with disease in multiple affected family members (PMID: 28782696; 25236808) - PP1_strong. In summary, the currently available evidence indicates that the variant is pathogenic. (less)
Number of individuals with the variant: 1
Sex: male
Geographic origin: Argentina
|
|
Likely pathogenic
(May 17, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Brugada syndrome 1
(Autosomal dominant inheritance)
Affected status: yes
Allele origin:
unknown
|
Institute of Human Genetics, University of Leipzig Medical Center
Accession: SCV004027728.1
First in ClinVar: Aug 26, 2023 Last updated: Aug 26, 2023 |
Comment:
Criteria applied: PS4,PS3_MOD,PM4,PM2_SUP
Clinical Features:
Generalized non-motor (absence) seizure (present)
Sex: female
|
|
Pathogenic
(Aug 28, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000545078.9
First in ClinVar: Apr 17, 2017 Last updated: Feb 20, 2024 |
Comment:
This variant, c.4850_4852del, results in the deletion of 1 amino acid(s) of the SCN5A protein (p.Phe1617del), but otherwise preserves the integrity of the reading frame. … (more)
This variant, c.4850_4852del, results in the deletion of 1 amino acid(s) of the SCN5A protein (p.Phe1617del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs749697698, gnomAD 0.003%). This variant has been observed in individuals with German-Dutch descent and long QT syndrome and sick sinus syndrome and long-QT syndrome and conduction disease and Brugada syndrome (PMID: 10973849, 14523039, 17081365, 19716085, 22840528, 28782696). It is commonly reported in individuals of Dutch ancestry (PMID: 10973849, 14523039, 17081365, 19716085, 22840528, 28782696). ClinVar contains an entry for this variant (Variation ID: 201572). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects SCN5A function (PMID: 15665061, 20448214). For these reasons, this variant has been classified as Pathogenic. (less)
|
|
Pathogenic
(Jul 13, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Clinical Genetics Laboratory, Skane University Hospital Lund
Accession: SCV005199068.1
First in ClinVar: Aug 25, 2024 Last updated: Aug 25, 2024 |
|
|
Likely pathogenic
(Oct 14, 2021)
|
no assertion criteria provided
Method: clinical testing
|
Long QT syndrome 3
Affected status: yes
Allele origin:
germline
|
Clinical Genetics Laboratory, University Hospital Schleswig-Holstein
Accession: SCV002029190.1
First in ClinVar: Dec 04, 2021 Last updated: Dec 04, 2021 |
|
|
click to load more click to collapse |
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Clinical characteristics and electrophysiologic properties of SCN5A variants in fever-induced Brugada syndrome. | Chen GX | EBioMedicine | 2023 | PMID: 36516610 |
Biventricular Myocardial Fibrosis and Sudden Death in Patients With Brugada Syndrome. | Miles C | Journal of the American College of Cardiology | 2021 | PMID: 34620408 |
Brugada syndrome genetics is associated with phenotype severity. | Ciconte G | European heart journal | 2021 | PMID: 33221895 |
Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls. | Walsh R | Genetics in medicine : official journal of the American College of Medical Genetics | 2021 | PMID: 32893267 |
Purkinje system hyperexcitability and ventricular arrhythmia risk in type 3 long QT syndrome. | Barake W | Heart rhythm | 2020 | PMID: 32454217 |
Heritability in a SCN5A-mutation founder population with increased female susceptibility to non-nocturnal ventricular tachyarrhythmia and sudden cardiac death. | Ter Bekke RMA | Heart rhythm | 2017 | PMID: 28782696 |
Congenital long QT syndrome: severe torsades de pointes provoked by epinephrine in a digenic mutation carrier. | Tan VH | Heart & lung : the journal of critical care | 2014 | PMID: 25236808 |
Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing. | Crotti L | Journal of the American College of Cardiology | 2012 | PMID: 22840528 |
Pathophysiological Mechanisms of Sino-Atrial Dysfunction and Ventricular Conduction Disease Associated with SCN5A Deficiency: Insights from Mouse Models. | Huang CL | Frontiers in physiology | 2012 | PMID: 22783200 |
The cardiac conduction system. | Park DS | Circulation | 2011 | PMID: 21357845 |
Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals. | Goldenberg I | Journal of the American College of Cardiology | 2011 | PMID: 21185501 |
Genetic analysis of Brugada syndrome and congenital long-QT syndrome type 3 in the Chinese. | Liang P | Journal of cardiovascular disease research | 2010 | PMID: 20877689 |
Multiple loss-of-function mechanisms contribute to SCN5A-related familial sick sinus syndrome. | Gui J | PloS one | 2010 | PMID: 20539757 |
Mechanistic links between Na+ channel (SCN5A) mutations and impaired cardiac pacemaking in sick sinus syndrome. | Butters TD | Circulation research | 2010 | PMID: 20448214 |
Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. | Kapplinger JD | Heart rhythm | 2009 | PMID: 19716085 |
SCN5A channelopathies--an update on mutations and mechanisms. | Zimmer T | Progress in biophysics and molecular biology | 2008 | PMID: 19027780 |
SCN5A overlap syndromes: no end to disease complexity? | Remme CA | Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology | 2008 | PMID: 18820249 |
SCN5A and sinoatrial node pacemaker function. | Lei M | Cardiovascular research | 2007 | PMID: 17368591 |
[Novel SCN5A gene mutations associated with Brugada syndrome: V95I, A1649V and delF1617]. | Liang P | Zhonghua xin xue guan bing za zhi | 2006 | PMID: 17081365 |
Reduced voltage dependence of inactivation in the SCN5A sodium channel mutation delF1617. | Chen T | American journal of physiology. Heart and circulatory physiology | 2005 | PMID: 15665061 |
Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). | Benson DW | The Journal of clinical investigation | 2003 | PMID: 14523039 |
Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. | Splawski I | Circulation | 2000 | PMID: 10973849 |
click to load more click to collapse |
Text-mined citations for rs749697698 ...
HelpRecord last updated Nov 03, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.